Symbol="INFI"
AssetType="Common Stock"
Name="Infinity Pharmaceuticals Inc"
Description="Infinity Pharmaceuticals, Inc., a biopharmaceutical company, is focused on developing new drugs for people with cancer. The company is headquartered in Cambridge, Massachusetts."
CIK="1113148"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1100 MASSACHUSETTS AVENUE, FLOOR 4, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="9062400"
EBITDA="-41618000"
PERatio="None"
PEGRatio="-0.05"
BookValue="-0.412"
DividendPerShare="0"
DividendYield="0"
EPS="-0.49"
RevenuePerShareTTM="0.029"
ProfitMargin="0"
OperatingMarginTTM="-16.37"
ReturnOnAssetsTTM="-0.632"
ReturnOnEquityTTM="-35.21"
RevenueTTM="2569000"
GrossProfitTTM="-31381000"
DilutedEPSTTM="-0.49"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.15"
AnalystTargetPrice="0.3"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="19.29"
PriceToBookRatio="8.03"
EVToRevenue="1.165"
EVToEBITDA="0.101"
Beta="1.372"
num_52WeekHigh="1.76"
num_52WeekLow="0.085"
num_50DayMovingAverage="0.177"
num_200DayMovingAverage="0.39"
SharesOutstanding="89905000"
DividendDate="None"
ExDividendDate="None"
symbol="INFI"
open="0.09"
high="0.11"
low="0.09"
price="0.11"
volume="5560705.00"
latest_trading_day="2023-08-16"
previous_close="0.09"
change="0.02"
change_percent="24.8581%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="76"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="24"
Volume_recent_avg="2283816"
Change_recent_avg="0.01"
Delta_recent_avg="0.02"
Variance_recent_avg="0.01"
Change_ratio_recent_avg="-0.08"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="24"
Aroon_momentum_negative="76"
image_negative_thumbnail_id_1="1106"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0139.jpeg"
image_negative_thumbnail_id_2="152"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0024.jpeg"
image_neutral_thumbnail_id_1="583"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_neutral_thumbnail_id_2="555"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_positive_thumbnail_id_1="998"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_positive_thumbnail_id_2="993"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_professor_thumbnail_id_1="1192"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
image_professor_thumbnail_id_2="1180"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
